# Vansen Pharma Inc.

Vansen Pharma Inc. is a company headquartered in Vancouver, Canada.

## Company overview

- **Legal name:** Vansen Pharma Inc.
- **Former names in filing history:** Okana Ventures, Inc. (2006-10-20 to 2013-08-19)
- **Classification:** Company
- **Industry (SIC):** 1040 — Gold and Silver Ores
- **Headquarters:** Vancouver, Canada
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001378076

## About

Vansen Pharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001378076, and its reported industry is Gold and Silver Ores. In 10-K filed on 2013-04-12, it reported net income of USD -37,148; total assets of USD 15,015 for the fiscal period ended 2012-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2012 (period ended 2012-12-31)

- **Net income:** -$37,148 (USD -37,148)
- **Total assets:** $15,015 (USD 15,015)
- **Cash and equivalents:** $15,015 (USD 15,015)
- **Operating cash flow:** -$28,751 (USD -28,751)

### FY2011 (period ended 2011-12-31)

- **Net income:** -$25,064 (USD -25,064)
- **Total assets:** $18,766 (USD 18,766)
- **Cash and equivalents:** $18,766 (USD 18,766)
- **Operating cash flow:** -$20,422 (USD -20,422)

## Recent SEC filings

- Form 8-K — filed 2015-03-27 — period 2014-11-14 — FORM 8-K
- Form 8-K — filed 2014-03-18 — period 2014-03-10 — FORM 8-K
- Form 8-K — filed 2014-03-03 — period 2014-02-24 — FORM 8-K
- Form 8-K — filed 2014-01-21 — period 2014-01-21 — FORM 8-K
- Form 10-Q — filed 2013-12-04 — period 2013-09-30 — FORM 10-Q
- Form 8-K — filed 2013-10-28 — period 2013-10-10 — FORM 8-K
- Form 8-K — filed 2013-08-30 — period 2013-08-20 — FORM 8-K
- Form 10-Q — filed 2013-08-19 — period 2013-06-30 — FORM 10-Q
- Form 8-K — filed 2013-08-08 — period 2013-07-30 — FORM 8-K
- Form 10-Q — filed 2013-05-09 — period 2013-03-31 — FORM 10-Q
- Form 10-K — filed 2013-04-12 — period 2012-12-31 — FORM 10-K
- Form 8-K — filed 2013-02-22 — period 2013-02-21 — FORM 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/vansen-pharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology